Targeted disruption of T cell receptor genes using talens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9937207
SERIAL NO

14221074

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are methods and compositions for modifying TCR genes, using nucleases (zinc finger nucleases or TAL nucleases) to modify TCR genes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INC501 CANAL BLVD SUITE A100 RICHMOND CA 94804

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bonini, Maria Chiara Milan, IT 14 350
Genovese, Pietro Milan, IT 13 356
Gregory, Philip D Richmond, US 75 3031
Holmes, Michael C Richmond, US 87 3590
Magnani, Zulma Milan, IT 2 107
Mastaglio, Sara Milan, IT 2 107
Naldini, Luigi Milan, IT 49 1043
Paschon, David Richmond, US 62 1887
Zhang, Lei Richmond, US 2462 17694

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 10, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 10, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00